Brief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
BRIEF-Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS June 16 (Reuters) - Poolbeg Pharma PLC POLB.L:
POOLBEG PHARMA PLC - EUROPEAN PATENT GRANTED FOR POLB 001 IN CRS
Source text: ID:nRSP3838Ia
Further company coverage: POLB.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Poolbeg Pharma
See all newsBrief: Poolbeg Pharma Says European Patent Granted For POLB 001 In CRS
PDMR Notification
Brief: Poolbeg Pharma Says FDA Feedback Broadly Aligned With Development Pathway For POLB 001
Brief: Poolbeg Pharma Announces Granted POLB 001 Cancer Immunotherapy-Induced CRS Patent In Canada
Annual Report & AGM Notice